Nixodine has emerged as a patented bio-alternative to nicotine, designed specifically for adult vapers seeking a similar experience without the tobacco derivative. Marketed as a vitamin B-based compound (specifically related to Nicotinamide), it contains zero nicotine yet mimics the pharmacological satisfaction and throat hit of traditional e-liquids. While it bypasses FDA tobacco regulations by not containing nicotine from any source, toxicology reports suggest it may still be habit-forming due to its similar receptor activation.